These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3363650)

  • 21. Improved early course after cadaveric renal transplantation by reducing the cyclosporine dose and adding azathioprine.
    Lundgren G; Albrechtsen D; Brynger H; Flatmark A; Frödin I; Gäbel H; Persson H; Groth CG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2074-9. PubMed ID: 3547910
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of the timing of antigen administration on synergistic immunosuppression with cyclosporine.
    Yoshimura N; Kahan BD
    Transplantation; 1985 Jul; 40(1):108-10. PubMed ID: 3892789
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunologic aspects of local immunosuppression in canine liver transplantation.
    Ko S; Nakajima Y; Kanehiro H; Taki J; Yagura K; Nakano H
    Transplant Proc; 1994 Apr; 26(2):849-50. PubMed ID: 8171686
    [No Abstract]   [Full Text] [Related]  

  • 24. Transdermal application of cyclosporine prolongs skin allograft survival.
    Black KS; Hewitt CW; Chau CL; Pizzo L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):660-2. PubMed ID: 3284115
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term acceptance of pancreatic allografts in rats during trough level-controlled cyclosporine A treatment.
    Loske G; Timmermann W; Schubert G; Leimenstoll G; Schang T; Stoffregen C; Thiede A
    Transplant Proc; 1987 Oct; 19(5):4334-5. PubMed ID: 3314037
    [No Abstract]   [Full Text] [Related]  

  • 26. Synergistic effect of cyclosporine and mizoribine on canine pancreas allograft survival.
    Hayashi R; Kenmochi T; Fukuoka T; Suzuki S; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1585-6. PubMed ID: 1989300
    [No Abstract]   [Full Text] [Related]  

  • 27. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The case against the indefinite use of cyclosporine.
    Myers BD; Newton L; Oyer P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):41-2. PubMed ID: 1990570
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine in transplantation of the liver in the dog.
    Williams JW; Peters TG; Haggitt R; Van Voorst S
    Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 31. An evaluation of leflunomide in the canine renal transplantation model.
    McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
    Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine-pretreated renal allografts.
    Toledo-Pereyra LH
    Transplantation; 1987 Jan; 43(1):165-6. PubMed ID: 3541318
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of cyclosporine on fresh and preserved orthotopic small bowel allografts.
    Toledo-Pereyra LH; Kaufmann RJ; Bergren CT
    P R Health Sci J; 1987 Dec; 6(3):147-52. PubMed ID: 3438458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo interaction of cyclosporine and Intralipid.
    Wassef R; Cohen Z; Langer B
    Transplantation; 1986 Feb; 41(2):266-8. PubMed ID: 3946015
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronomodulatory effect of cyclosporine upon survival of DBA mice with L1210 leukemia.
    Sánchez de la Peña S; Halberg E; Halberg F; Sánchez E; Cornélissen G
    Chronobiologia; 1986; 13(2):129-35. PubMed ID: 3731947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved immunosuppression for heart transplantation.
    Bolman RM; Elick B; Olivari MT; Ring WS; Arentzen CE
    J Heart Transplant; 1985 May; 4(3):315-8. PubMed ID: 3916502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of five cyclosporine-prednisone regimens for induction of immunosuppression in cadaveric kidney recipients: a retrospective analysis of 245 cases.
    Kahan BD; Lorber MI; Flechner SM; Van Buren CT; Jensen C; Wideman CA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):59-65. PubMed ID: 3515696
    [No Abstract]   [Full Text] [Related]  

  • 40. The plasma time course of orally-administered cyclosporine in the dog.
    Buice RG; Gurley BJ; Sidhu P
    Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):143-6. PubMed ID: 4081308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.